Oxford Biodynamics PLC (OBD) - Net Assets

Latest as of September 2025: GBX1.12 Million GBX ≈ $135.78 USD

Based on the latest financial reports, Oxford Biodynamics PLC (OBD) has net assets worth GBX1.12 Million GBX (≈ $135.78 USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (GBX8.09 Million ≈ $983.83 USD) and total liabilities (GBX6.97 Million ≈ $848.05 USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore total assets of Oxford Biodynamics PLC for the complete picture of this company's asset base.

Key Net Assets Metrics

Metric Value
Current Net Assets GBX1.12 Million
% of Total Assets 13.8%
Annual Growth Rate -7.75%
5-Year Change -83.33%
10-Year Change -85.59%
Growth Volatility 63.87

Oxford Biodynamics PLC - Net Assets Trend (2013–2025)

This chart illustrates how Oxford Biodynamics PLC's net assets have evolved over time, based on quarterly financial data. Check tangible net worth ratio of Oxford Biodynamics PLC to evaluate the tangible quality of the company's equity base.

Annual Net Assets for Oxford Biodynamics PLC (2013–2025)

The table below shows the annual net assets of Oxford Biodynamics PLC from 2013 to 2025. For live valuation and market cap data, see Oxford Biodynamics PLC market capitalisation.

Year Net Assets Change
2025-09-30 GBX1.12 Million
≈ $135.78		 -74.39%
2024-09-30 GBX4.36 Million
≈ $530.24		 -28.03%
2023-09-30 GBX6.05 Million
≈ $736.72		 +133.96%
2022-09-30 GBX2.59 Million
≈ $314.88		 -61.33%
2021-09-30 GBX6.69 Million
≈ $814.34		 -50.72%
2020-09-30 GBX13.58 Million
≈ $1.65K		 -22.81%
2019-09-30 GBX17.59 Million
≈ $2.14K		 -12.24%
2018-09-30 GBX20.05 Million
≈ $2.44K		 +72.91%
2017-09-30 GBX11.60 Million
≈ $1.41K		 +49.75%
2016-09-30 GBX7.74 Million
≈ $942.10		 -14.37%
2015-09-30 GBX9.04 Million
≈ $1.10K		 +72.72%
2014-09-30 GBX5.24 Million
≈ $636.95		 +78.18%
2013-09-30 GBX2.94 Million
≈ $357.47		 --

Equity Component Analysis

This analysis shows how different components contribute to Oxford Biodynamics PLC's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 4658900000.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (September 2025)

Component Amount Percentage
Common Stock GBX4.83 Million 432.89%
Other Comprehensive Income GBX3.08 Million 275.54%
Other Components GBX45.38 Million 4066.22%
Total Equity GBX1.12 Million 100.00%

Oxford Biodynamics PLC Competitors by Market Cap

The table below lists competitors of Oxford Biodynamics PLC ranked by their market capitalization.

Company Market Cap
Fadel Partners Inc
LSE:FADL
 $59.08K
Serinus Energy
LSE:SENX
 $59.54K
Tiger Royalties and investments Plc
LSE:TIR
 $59.71K
Amur Minerals Corporation
LSE:CRTX
 $59.80K
Philipp Holzmann AG
DU:HOZ
 $57.22K
Harmony Energy Income Trust PLC
LSE:HEIT
 $57.20K
Bisichi Mining PLC
LSE:BISI
 $57.16K
MOLECULE HOLDINGS
F:ERV2
 $57.16K

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Oxford Biodynamics PLC's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 4,358,000 to 1,116,000, a change of -3,242,000 (-74.4%).
  • Net loss of 11,153,000 reduced equity.
  • New share issuances of 7,440,000 increased equity.
  • Other comprehensive income decreased equity by 134,000.
  • Other factors increased equity by 605,000.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income GBX-11.15 Million -999.37%
Share Issuances GBX7.44 Million +666.67%
Other Comprehensive Income GBX-134.00K -12.01%
Other Changes GBX605.00K +54.21%
Total Change GBX- -74.39%

Book Value vs Market Value Analysis

This analysis compares Oxford Biodynamics PLC's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 136.72x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
  • The price-to-book ratio has increased from 0.48x to 136.72x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2013-09-30 GBX0.23 GBX0.11 x
2014-09-30 GBX0.41 GBX0.11 x
2015-09-30 GBX0.10 GBX0.11 x
2016-09-30 GBX0.09 GBX0.11 x
2017-09-30 GBX0.14 GBX0.11 x
2018-09-30 GBX0.23 GBX0.11 x
2019-09-30 GBX0.19 GBX0.11 x
2020-09-30 GBX0.15 GBX0.11 x
2021-09-30 GBX0.07 GBX0.11 x
2022-09-30 GBX0.03 GBX0.11 x
2023-09-30 GBX0.04 GBX0.11 x
2024-09-30 GBX0.02 GBX0.11 x
2025-09-30 GBX0.00 GBX0.11 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Oxford Biodynamics PLC utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -999.37%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -1018.54%
  • • Asset Turnover: 0.14x
  • • Equity Multiplier: 7.25x
  • Recent ROE (-999.37%) is below the historical average (-152.08%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2013 -36.12% -301.43% 0.10x 1.23x GBX-1.35 Million
2014 -14.10% -111.68% 0.11x 1.18x GBX-1.26 Million
2015 -11.13% -143.16% 0.07x 1.08x GBX-1.91 Million
2016 -22.40% -158.57% 0.12x 1.17x GBX-2.50 Million
2017 -32.86% -321.56% 0.09x 1.10x GBX-4.96 Million
2018 -9.75% -164.67% 0.06x 1.05x GBX-3.96 Million
2019 -15.93% -308.71% 0.05x 1.07x GBX-4.56 Million
2020 -31.80% -945.83% 0.03x 1.13x GBX-5.67 Million
2021 -100.09% -1959.53% 0.02x 2.30x GBX-7.35 Million
2022 -259.27% -4357.14% 0.01x 4.38x GBX-6.97 Million
2023 -178.79% -2122.75% 0.03x 2.66x GBX-11.43 Million
2024 -265.42% -1818.71% 0.05x 2.78x GBX-12.00 Million
2025 -999.37% -1018.54% 0.14x 7.25x GBX-11.26 Million

Industry Comparison

This section compares Oxford Biodynamics PLC's net assets metrics with peer companies in the Diagnostics & Research industry.

Industry Context

  • Industry: Diagnostics & Research
  • Average net assets among peers: $337,953,698
  • Average return on equity (ROE) among peers: -25.60%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Oxford Biodynamics PLC (OBD) GBX1.12 Million -36.12% 6.25x $57.43K
Abingdon Health Plc (ABDX) $3.01 Million -115.29% 1.01x $320.76K
ANGLE plc (AGL) $7.22 Million 16.76% 0.27x $94.18K
genedrive plc (GDR) $8.86 Million -2.75% 0.18x $125.27K
Integrated Diagnostics Holdings PLC (IDHC) $2.31 Billion 16.16% 0.34x $319.73 Million
LungLife AI Inc (LLAI) $13.14 Million -57.88% 0.14x $15.48K
Proteome Sciences PLC (PRM) $-270.00K 0.00% 0.00x $76.81K
Verici Dx Plc (VRCI) $19.62 Million -36.19% 0.03x $41.43K

About Oxford Biodynamics PLC

LSE:OBD UK Diagnostics & Research
Market Cap
$57.43K
GBX472.00 Million GBX
Market Cap Rank
#31468 Global
#1183 in UK
Share Price
GBX0.11
Change (1 day)
-4.35%
52-Week Range
GBX0.09 - GBX0.59
All Time High
GBX274.50
Categories
Companies in UK Diagnostics & Research
About

Oxford BioDynamics Plc, together with its subsidiaries, operates as a biotechnology company that y developing, and commercializing precision medicine tests for life-changing diseases in the United States and the United Kingdom. The company provides EpiSwitch CiRT (Checkpoint inhibitor Response Test), a blood test that predicts an individual patient's therapeutic response to checkpoint inhibitor i… Read more